Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnosine in patients with schizophrenia
IRCT201504211556N75Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of carnosine in schizophrenia, sponsored by Tehran University of Medical Sciences. Started May 2015; status: completed.
02
Drugs
carnosine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201504211556N75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201504211556N75.